Friday 6 November 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024.
- Revenue
- +3.01%
- EPS
- +223.8%
- Free cash flow
- −12.5%
- Total debt
- −7.64%
Quarter to September 2026, against a year earlier
12.82
0.97
−7.03%
Follow CC
Alert me
The Chemours Company (CC) P/E ratio
The Chemours Company has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 954× (March 2017) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 38.3× | — |
| FY2023 | 0.0× | — |
| FY2022 | 8.4× | (7.01%) |
| FY2021 | 9.0× | (51.10%) |
| FY2020 | 18.5× | — |
| FY2019 | 0.0× | — |
| FY2018 | 5.0× | (60.65%) |
| FY2017 | 12.8× | (97.59%) |
| FY2016 | 531× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 954×
Ten-year median
6.8×
Current reading's percentile
36
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| CC The Chemours Company | n/m |
| MTX Minerals Technologies Inc. compare | n/m |
| FUL H. B. Fuller Company compare | 13.8× |
| IOSP Innospec Inc. compare | 13.9× |
| KWR Quaker Houghton compare | 27.2× |
| WDFC WD-40 Company compare | 37.0× |
| NGVT Ingevity Corporation compare | 42.0× |
| SCL Stepan Company compare | 361× |
| STDN Standard Nuclear Inc compare | — |
| Specialty Chemicals industry median | 24.5× |
| Basic Materials sector median | 19.0× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement